Biospark Partners with xCures to Advance New Oncology Real World Dataset

Biospark and xCures have announced a new partnership to develop and release a new dataset comprised of outcomes data from over 40,000 cancer patients. The database will harmonize electronic health records (EHR) into a case report form (CRF) structure that will facilitate oncology research and inform clinicians treating cancer patients.

According to an xCures press release, “Highly useful for precision medicine, these data are particularly rich in genetic markers and biomarkers and offer complete longitudinal research-grade oncology outcomes, such as formal criteria-based tumor response or progression-free survival.”

To read the full press release, click here.

(Source: Ein Newswires, March 3^rd, 2022)